Research News and Research

RSS

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

SkyePharma PLC has announced that its proprietary delivery technologies for respiratory drugs will be presented later this month at two international conferences, one in the UK and one in America.

22 Apr 2004

Adult ADHD screening in New York

Despite wide recognition as a children’s disorder, ADHD (Attention-Deficit/Hyperactivity Disorder) affects millions of adults who are undiagnosed and untreated.

22 Apr 2004

Doctors from the University of Edinburgh and local intensive care units have linked to fight an antibiotic-resistant infection which attacks some hospital patients.

22 Apr 2004

Expert calls for standard epinephrine doses when treating children in cardiac arrest

Medical personnel attempting to resuscitate a child in cardiac arrest should abide by epinephrine dosing levels outlined in the Pediatric Advanced Life Support (PALS) guidelines rather than giving larger amounts of the drug, says a nationally recognized pediatrician from UT Southwestern Medical Center at Dallas.

22 Apr 2004

Fish oil reduces heart attack and blood vessel disease

Fish oil can help reduce deaths from heart disease, according to new evidence reports announced today by the Agency for Healthcare Research and Quality.

22 Apr 2004

Supplements help prevent cavities in children where water quality and fluoride content is poor

Primary care clinicians who practice in areas where the water supply is deficient in fluoride should prescribe oral fluoride supplements to preschool children over the age of 6 months, according to a recommendation from the U.S. Preventive Services Task Force.

22 Apr 2004

Genetically engineered bugs to fight cancer

GENETICALLY engineered bacteria could become the latest weapons against cancer, Cancer Research UK scientists suggest in a study published today 22nd April 2004.

22 Apr 2004

Prediction of adult diseases in infancy

A new way of predicting which young children are most at risk of eventually contracting diabetes and heart disease in adult life is being developed by researchers at Cambridge University - with help from Bristol’s Children of the 90s.

22 Apr 2004

New survey on the U.S. market for synthetic oligonucleotides

According to a recent survey, the overwhelming majority (91%) of scientific customers have not changed their primary supplier of custom synthetic oligonucleotides (oligos) over the past 12 months.

From Integrated DNA Technologies 22 Apr 2004

Turmeric corrects the cystic fibrosis defect

Scientists at The Hospital for Sick Children (Sick Kids) and Yale University School of Medicine have found that a compound in the spice turmeric corrects the cystic fibrosis defect in mice. This research is reported in the April 23, 2004 issue of the journal Science.

22 Apr 2004

FDA approves new breakthrough Parkinson's drug

FDA has approved Apokyn (apomorphine) as an injectable drug for treating Parkinson's patients during episodes of "hypomobility," so-called "off periods" in which the patient becomes immobile or unable to perform activities of daily living.

21 Apr 2004

Teenagers being bombarded by alchohol advertising

Alcohol advertising on television, and youth exposure to it, grew substantially in 2002 from 2001, and although new industry marketing codes were announced in 2003, they will still allow for substantial youth overexposure to alcohol ads, according to a study released today by the Center on Alcohol Marketing and Youth at Georgetown University.

21 Apr 2004

500,000 patients have now been treated with REMICADE® worldwide

Centocor, Inc., announced today that more than a half million patients worldwide have now been treated with the anti-TNF agent REMICADE® (infliximab) since it was introduced in the United States five years ago.

21 Apr 2004

FDA revises guidance on changes to an approved NDA, ANDA

FDA has issued a revised guidance to help drugmakers determine how they should report postapproval manufacturing changes to new drug applications (NDAs) or abbreviated new drug applications (ANDAs).

21 Apr 2004

No relationship between HIV and oral polio vaccine

HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist

21 Apr 2004

Common anemia drug may protect hearts of infants undergoing surgical repair of congenital defects

Medical College of Wisconsin researchers may have promising news for the many infants who are born with a congenital heart defect serious enough to require surgery before their first birthday.

21 Apr 2004

Cell associated with asthma linked to tobacco smoke

Diminished production of dendritic cell interleukin 10 (IL-10), an anti-inflammatory cytokine previously associated with asthma, is linked to environmental tobacco smoke during infancy in a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

21 Apr 2004

Desensitization Useful for Allergy to Life-Saving Drug

When patients with life-threatening bacterial infections are allergic to antibiotics, drug desensitization may be an option when no other alternative exists according to a report published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

21 Apr 2004

Scientist discovers why skin turns leathery

“The reason our skin becomes more leathery and thick as we age might be due to a loss of elasticity in the cells,” says Igor Sokolov of Clarkson University, who presented his latest research findings during a session on bio-imaging techniques at the Annual American Physical Society (APS) March meeting in Montreal.

21 Apr 2004